Skip to content
Search

Latest Stories

Pakistan reports around 1,500 fresh COVID-19 cases in a day

PAKISTAN's total number of coronavirus cases reached 35,788 after 1,452 new infections were reported, while the death toll rose to 770 with 33 fresh fatalities, the health ministry said Thursday (14).

The spread of the deadly disease through local transmission showed a dangerous upward trajectory, reports said.


According to the ministry of national health services, Punjab province reported 13,561 cases, Sindh 13,341, Khyber-Pakhtunkhwa 5,252, Balochistan 2,239, Islamabad 822, Gilgit-Baltistan 482 and Pakistan-occupied Kashmir 91 cases.

A total of 9,695 people have fully recovered, shows the latest data.  So far, 330,750 tests have been conducted, including 13,051 in the last 24 hours.

According to a report published by the World Health Organisation Pakistan chapter, the spread of the infection through local transmission showed a dangerous upward trajectory.

Balochistan province showed the highest rate of local transmission at 93 per cent, followed by Sindh (92 per cent), Punjab (85 per cent), Khyber Pakhtunkhwa (84 per cent) and Gilgit-Baltistan (63 per cent), local media reported.

Meanwhile, the Peshawar High Court (PHC) has been closed until May 31 after some of the staff members tested positive for the novel coronavirus.

According to a notification of the PHC Registrar, except the necessary staff, all the offices, branches, bar rooms, advocate general block, consultation room, library and bookshop of the high court will remain closed.

The Pakistan government announced last week that it would begin a phased lifting of the lockdown due to its effect on the economy and the workforce.  As the lockdown was eased, trade activities were resumed with Iran at Taftan after two trade gateways were reopened.

They were closed for two-and-a-half months due to the coronavirus pandemic restrictions.

Ferozsons Laboratories, a local Pakistani company, announced that its subsidiary BF Biosciences Ltd (BFBL) has signed a non-exclusive license agreement with Gilead Sciences Inc for manufacturing and selling remdesivir, an experimental antiviral drug allowed by the US authorities to be used to treat coronavirus patients.

More For You

Mohua Chinappa

She believes her work is shaped by a single purpose: giving voice to those who have been unheard for far too long

Mohua Chinappa

Mohua Chinappa on why homemakers, their unseen labour, and midlife reinvention can no longer be ignored

Highlights

  • Mohua Chinappa says advocacy for homemakers and marginalised women drives her work
  • She calls unpaid domestic labour a long-ignored injustice in Indian households
  • Chinappa describes midlife as a moment of freedom, not decline, for South Asian women

Writer, podcaster and advocate Mohua Chinappa says the stories that matter most to her are those that rarely make it into the spotlight. From homemakers to queer communities, she believes her work is shaped by a single purpose: giving voice to those who have been unheard for far too long.

Speaking in a recent conversation, Chinappa draws directly from her own life to explain why the quiet labour of women, especially homemakers, needs urgent recognition.

Keep ReadingShow less